Brain Radiotherapy May Not Be Necessary for Patients with Lung Cancer Metastases
By MedImaging International staff writers Posted on 13 Sep 2016 |
Image: The image displays an example of Hippocampal-sparing whole brain radiotherapy (Photo courtesy of ResearchGate).
The results of a phase 3 randomized trial have revealed that there was no beneficial effect in terms of survival rate or quality of life, for patients who underwent whole brain radiotherapy, compared to those who received only steroid treatment and supportive care.
The results indicate that patients suffering from a common form of lung cancer, with brain metastases may not need to undergo whole brain radiotherapy that can result in substantial harmful side effects such as nausea, fatigue and neurotoxicity.
The research was published in the August 2016 online edition of the journal The Lancet. The researchers found that whole brain radiotherapy could be beneficial in patients below the age of 60, but should not be used for standard treatment of most patients suffering from Non-Small Cell Lung Cancer (NSCLC) with brain metastases.
According to the researchers 11% of the participants randomized to whole-brain radiotherapy were too ill or died before they could receive the treatment. The assessment of quality-of-life was also limited, in order not to overburden the seriously ill patients.
Study author, Dr Paula Mulvenna, consultant clinical oncologist at the Newcastle Hospitals NHS Foundation Trust (Newcastle upon Tyne, UK), said, "Whole brain radiotherapy was widely adopted into clinical practice based on the assumption it improves tumor control in patients with brain metastases. But in our lung cancer clinics, we were not seeing the improvements we had hoped for in our patients. Survival times are poor and have hardly changed since the 1980s. What's more, the technique's toxicity can be substantial and it can damage cognitive function."
Related Links:
Newcastle Hospitals NHS Foundation Trust
The results indicate that patients suffering from a common form of lung cancer, with brain metastases may not need to undergo whole brain radiotherapy that can result in substantial harmful side effects such as nausea, fatigue and neurotoxicity.
The research was published in the August 2016 online edition of the journal The Lancet. The researchers found that whole brain radiotherapy could be beneficial in patients below the age of 60, but should not be used for standard treatment of most patients suffering from Non-Small Cell Lung Cancer (NSCLC) with brain metastases.
According to the researchers 11% of the participants randomized to whole-brain radiotherapy were too ill or died before they could receive the treatment. The assessment of quality-of-life was also limited, in order not to overburden the seriously ill patients.
Study author, Dr Paula Mulvenna, consultant clinical oncologist at the Newcastle Hospitals NHS Foundation Trust (Newcastle upon Tyne, UK), said, "Whole brain radiotherapy was widely adopted into clinical practice based on the assumption it improves tumor control in patients with brain metastases. But in our lung cancer clinics, we were not seeing the improvements we had hoped for in our patients. Survival times are poor and have hardly changed since the 1980s. What's more, the technique's toxicity can be substantial and it can damage cognitive function."
Related Links:
Newcastle Hospitals NHS Foundation Trust
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection